NeoGenomics, Inc.
NEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $1 | $1 | $1 | $0 |
| % Growth | 11.6% | 16.1% | 5.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 43.9% | 41.3% | 36.9% | 38.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -0.2% | -3% | -16.2% | -13.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -11.9% | -14.9% | -28.3% | -1.7% |
| EPS Diluted | -3.1 | -3.5 | -5.8 | -0.35 |
| % Growth | 11.4% | 39.7% | -1,557.1% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |